Followers | 7 |
Posts | 5499 |
Boards Moderated | 0 |
Alias Born | 09/11/2013 |
Sunday, April 30, 2017 1:23:42 PM
http://www.nanoviricides.com/press%20releases/2014/NanoViricides,%20Inc.%20Announces%20It%20Has%20Commenced%20Action%20Against%20Seeking%20Alpha%20to%20Obtain%20Identity%20of%20the%20Anonymous%20Short%20Seller.html
WEST HAVEN, CONNECTICUT -- Wednesday, March 5th, 2014 -- NanoViricides, Inc. (NYSE MKT: NNVC) announces that it has filed a special proceeding in the Supreme Court of the State of New York to compel Seeking Alpha to disclose the identity of the person who wrote and published a defamatory, malicious, and libelous article about the Company on February 11, 2014, on the Seeking Alpha website. The writer identified self as a short seller in the article. The Company believes that the writer and/or others with whom the writer was in contact, had established and maintained a significant short position in the Company's common stock, and that these parties in collusion profited from the drop in the Company's share price that occurred subsequent to the posting of the article, at the expense of the Company's shareholders and the Company's position.
The said article published on the "Seeking Alpha" website by the anonymous write who called self "Pump Terminator"contained patently false, malicious, and defamatory statements, and constituted a premeditated, unsupported attack on the Company with the intent to injure and disparage the Company and its shareholders, and manipulate the market for the Company's stock and the Company's financial position.
The Company intends to commence an action against Pump Terminator, and anyone else that we discover to be responsible in connection with the article, to recover the damages caused to the Company and its shareholders. The Company also intends to provide the information it discovers to the relevant regulatory authorities for potential criminal investigation into the activities of the short seller and associates. The Company has already filed a complaint with the regulatory authorities regarding this matter. In addition, the New York Stock Exchange ("NYSE") has notified the Financial Regulatory Authority ("FINRA") of potential market manipulation and unusual activity in the market for the Company's stock.
The Company previously requested that the website "Seeking Alpha" immediately remove the article from their site. As of today's date, Seeking Alpha has failed to comply with this simple request, thereby becoming a complicit agent in the criminal act(s) perpetrated by the article author and collaborators-in-action.
"Many investors were panicked into selling their positions or were forced out by market limit orders," said Eugene Seymour, MD, MPH, CEO of NanoViricides. "We noted a very suspicious and rapid rise in short selling activity in the days preceding the publication of the article. This suggested to us that there was collusion between the writer and others, or possibly that the writer alone was responsible for the entire short selling. This information has been forwarded to the appropriate regulatory authorities. We will aggressively pursue all available remedies against anyone responsible for such blatant market manipulation."
Recent NNVC News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:30:41 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 08:44:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/01/2023 08:46:45 PM
- Clinical Trial of Broad-Spectrum Antiviral Drug NV-CoV-2 is Progressing Well, Says NanoViricides - NV-CoV-2 is Positioned to Fulfill Many Unmet Medical Needs • InvestorsHub NewsWire • 07/06/2023 03:16:37 PM
- NanoViricides, Inc. to Present at The Inaugural Ef Hutton Global Conference on May 10, 2023 in New York City • GlobeNewswire Inc. • 05/04/2023 10:45:00 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM